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Abstract 
Purpose: To investigate the apoptotic activity, cell proliferation inhibition and different signaling protein 
expressions after treatment with a new isothiocyanate, sulforaphene, in human cervical cancer (HeLa) 
cells.  
Methods: Cytotoxicity was analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay after sulforaphene treatment for 3, 6, 12 and 24 h. Apoptosis assay, cell cycle analysis, 
intracellular oxygen species (ROS) measurement, mitochondrial membrane depolarization and western 
blot analysis were performed in four time-intervals to explore sulforaphene activity.  
Results: HeLa cell viability was reduced by sulforaphene dose and time dependently. ROS plays a 
causative role in sulforaphene induced cytotoxicity and apoptosis during which stimulation of Bax and 
blocking of Bcl2 were involved. Mitochondrial membrane potential depletion and cytochrome C, AIF 
modulation suggest mitochondrial pathway for the apoptosis. Activation of caspase -9, -8 and -3 in 
treated HeLa cells demonstrated caspase-dependent apoptosis by sulforaphene. Again, sulforaphene 
induced HeLa cell proliferation inhibition was evidenced by cell cycle arrest and PTEN/PI3Kinase 
modulation.  
Conclusion: Dietary sulforaphene induces HeLa cell apoptosis by enhancing intracellular ROS levels, 
thereby activating multiple apoptotic signal cascades. Therefore, sulforaphene is a potential candidate 
for anticancer therapy.  
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Cervical cancer ranked third in female cancer 
worldwide and this cancer related death was in 
fifth position among Korean females [1]. Although 
surgery, chemo-radiotherapy and HPV vaccines 
are being used in cervical cancer treatment, 
however complications like bone marrow 
suppression, nerve injury, gastrointestinal 
adverse reactions, and renal impairment are also 
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matters of concern [2-5]. Therefore recent 
research is interested in the validation of some 
natural anticancer agents to provide an effective 
cancer remedial measure without any treatment 
related complications [6,7]. 
 
Dietary cruciferous vegetables have shown 
substantial protective role against various 
cancers and received much attention to the 
scientist in cancer management [8-11]. 
Traditionally radish has long been used as 
carminative, diuretic, expectorant, laxative and 
stomachic agents, especially as anti-cancer 
and/or anti-inflammatory agents in Asian 
countries [12]. Anticancer efficacy of radish 
extract in different solvents has been mentioned 
in some previous studies. This anticancer 
efficacy is mainly due to the presence of several 
isothiocyanates (ITC) in radish [11,13].  4-
Isothiocyanato-4R-(methylsulfinyl) -1-butene 
widely known as sulforaphene (PubChem CID 
6433206) is one of the major ITC present in 
radish (Raphanus sativus sp.). Sulforaphene was 
reported to have antimicrobial and antiviral 
activities with antioxidant efficacy in rat 
carcinogens [14,15]. Again sulforaphene inhibits 
food-derived heterocyclic amine-induced 
bacterial mutagenesis in TA100 [16]. In previous 
studies, sulforaphene was found to induce 
apoptosis in different colon cancer cell lines such 
as LoVo, HCT-116 and HT-29, H3-T1-1 followed 
by reduction in cancer cell proliferation [17]. 
Recently, sulforaphene was reported to have 
human breast cancer SUM159 cell migration 
inhibition efficacy by the down-regulation of 
Hedgehog signaling [18]. However, the molecular 
signaling pathways for sulforaphene activity in 
cancer cells have not extensively been studied 
yet. 
 
Previous studies reported that inhibition of 
phosphatase and tensin homolog (PTEN) and 
thereby overexpression phosphatidylinositol 3-
kinase (PI3Kinase) in cervical cancer tissues was 
found very common. Activation of PI3kinase in 
cancer cells is associated with increased 
tumorigenesis which includes cancer cell 
proliferation and cell cycle progression. On the 
other hand PTEN negatively regulates PI3kinase 
activity and inhibits cancer cell proliferation 
[19,20]. Thus, effectively downregulation of 
PI3Kinase by upregulated PTEN, is considered 
as one of the novel therapeutic strategy for 
human cervical cancer management. 
 
Therefore, in the present study our objectives 
were (i) to investigate the cytotoxicity and 
apoptosis inducing activity of dietary 
isothiocyanate sulforaphene on HeLa cells (ii) to 
analyze the ROS-production-based signaling 
protein expressions preliminarily associated with 
sulforaphene treated HeLa cell apoptosis (iii) to 
check whether sulforaphene has the ability to 
cease HeLa cell proliferation by increasing PTEN 






S-Sulforaphene was purchased from LKT 
Laboratories, Inc, USA and dissolved in DPBS to 
make 50 mg/mL stock solution. From the stock 
solution, we diluted all respective treatment 
concentrations in the culture media before the 
treatment. 3-[4,5-dimethylthiazol-2-yl] -2,5-
diphenyl-tetrazolium bromide (MTT), dimethyl 
sulfoxide (DMSO), Hoechst33342, propidium 
iodide (PI), RIPA buffer, protease and 
phosphatase inhibitors were purchased from 
Sigma (Saint Louis, MO, USA). H2DCFDA was 
obtained from Invitrogen (Eugene, OR, United 
States). Rhodamine123 was purchased from 
Molecular Probes Inc. (Eugene, OR, United 
States). Bradford Reagent was supplied by Bio-
Rad (Hercules, CA, USA). Poly (ADP-Ribose) 
polymerase (PARP) and caspase 3 were 
purchased from Calbiochem (CA, USA). 
Caspase-9 was purchased from cell signaling 
technology (Beverley, MA, USA). Cytochrome c, 
Bax, Bcl2, AIF (apoptosis-inducing factor), 
caspase 8, PTEN, PI3Kinase and β-actin were 
purchased from Santa Cruz Biotechnology, Inc. 




Human cervical cancer (HeLa) cells were 
cultured in DMEM (HyClone, South Logan, UT) 
supplemented with 10 % fetal bovine serum 
(FBS) (Equitech-Bio Inc, Texas) and 1 % 
streptomycin/penicillin (Gibco, BRL). The cells 
were maintained at 37 ºC in a 5 % CO2 
humidified environment. We used all 
experimental cell culture dishes from SPL Life 
Science (Pocheon, South Korea).  
 
Cytotoxicity assay  
 
HeLa cells were inoculated into a 96-well, flat-
bottomed microplate at a volume of 100 µl (1 x 
105 cells/ ml) in complete growth medium. The 
cells were treated with a series of sulforaphene 
(0 µg/mL - 100 µg/mL) with new fresh media. 
Cells were incubated for 3, 6, 12 and 24 h and 50 
µL MTT solutions (2mg/ mL) were added to each 
well. After incubation for 4 h in 5 % CO2 at 37 ºC, 
the media of each well was removed and 150 µL 
DMSO was added to dissolve violet blue crystals. 
The concentrations were determined by 
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measuring the absorbance at 570 nm using 
ELISA reader (Biochrom, UK). Cell cytotoxicity 
was expressed as the percentage of absorbance 
of treated cells with respect to that of control 
cells. The results were obtained from the mean 
values and standard deviation (SD) from at least 
three independent experiments. From the MTT 
assay 12 µg/mL sulforaphene concentration was 
selected for our further studies. 
 
Apoptosis assay  
 
To evaluate the morphological changes of the 
nuclear chromatin after apoptosis and necrosis 
induction in HeLa cells, Hoechst33342 and 
propidium iodide (PI, Sigma, St. Louis, USA) 
double staining was performed. Cells were 
treated with 12 µg/mL sulforaphene and 
incubated for 3, 6, 12 and 24 h in 5 % CO2 at 37 
ºC. Then the cells were incubated with Hoechst 
33342 (1µg/mL) for 30 min and PI (1 µg/mL) for 
15 min. The stained cells were observed to 
assess cellular apoptosis and necrosis using a 
confocal laser scanning microscope (Zeiss 510 
Meta, Germany) under equivalent conditions. 
Histogram was prepared to evaluate the 
percentage decrease in normal cells and the 
percentage of increase in apoptotic cells in 
different time intervals before and after 
sulforaphene treatment by counting cells from 
three different sets of samples. 
 
Analysis of cell cycle progression  
 
To evaluate time dependent sub-G1 DNA 
content after sulforaphene treatment, cell cycle 
analysis was performed. Briefly, HeLa cells were 
treated with 12 µg/mL of sulforaphene and 
incubated for 3, 6, 12 and 24 h, and were 
incubated with PI mixed with DPBS for 15 
minutes at room temperature. The DNA contents 
in each treatment were analyzed by flow 
cytometry (Accuri C6, BD, CA, USA). The 
percentages of viable and dead cells were 
determined as 10,000 events per sample using a 
FL-2 filter. Histogram was prepared and 
evaluated for the percentage of cell count in 
different sub populations in different time 
intervals after sulforaphene treatment from three 
different sets of samples. 
 
Evaluation of intracellular ROS generation 
 
To analyze intracellular ROS levels after 
sulforaphene treatment in HeLa cell, H2DCF-DA 
(2', 7'-Dichlorodihydro fluorescein diacetate, 
Molecular Probes, OR) was used as the oxidant 
sensitive fluorescent probe. The cells were 
treated with 12 µg/ ml sulforaphene as 
mentioned previously, and incubated for 3, 6, 12 
and 24 h. Cells were centrifuged at 1000 rpm for 
5 min and incubated with 20 µM of H2DCF-DA at 
37 ºC for 30 min. The fluorescent intensities of 
stained 10,000 cells were subjected to 
fluorescence-activated cell sorting using FL-1A 
filter of flow cytometer at different incubation time 
after sulforaphene treatment. Data was analyzed 
using Accuri C6 software. Histogram was 
prepared and evaluated for the percentage of 
increase in ROS in treated cells in different time 
intervals after sulforaphene treatment from three 
different sets of samples. 
 
Determination of changes in mitochondrial 
membrane potential (Δψm)  
 
The potential-dependent accumulation of 
fluorescent cationic dye rhodamine123 is used to 
analyze the changes in mitochondrial membrane 
potential in HeLa cells. Briefly, the cells were 
treated with 12 µg/ mL of sulforaphene and 
incubated for 3, 6, 12 and 24 h, then. 10 mM 
rhodamine123 in pre-incubated media were 
added to each well and incubated for 30 minutes 
at 37 ºC. The intensities of green fluorescence of 
cells were observed by laser scanning confocal 
microscope (Zeiss 510 Meta, Germany) under 
equivalent conditions. A histogram was prepared 
by measuring the fluorescence intensities from 
three different sets of samples at different 
intervals of time. The quantitative changes in 
rhodamine123 fluorescence were determined by 
flow cytometry. Cells were then centrifuged at 
1000 rpm for 5 min and then incubated with 
10μM of rhodamine123 for 30 min. The 
fluorescent intensities of cells were subjected to 
fluorescence-activated cell sorting using FL-1A 
filter of flow cytometer at different incubation 
times after sulforaphene treatment. Data were 
analyzed using BD Accuri C6 software.  
 
Assessment of caspase 3 activity  
 
To study the time-dependent activation of 
caspase 3 by sulforaphene treatment 
CaspGLOW Red Active Caspase 3 Staining kit 
was purchased from BioVision, USA. 12 μg/mL 
sulforaphene was to HeLa cells were treated with 
12 µg/mL sulforaphere for 3, 6, 12 and 24 h and 
subjected caspase 3 staining to according to the 
manufacturer’s protocol. Relative fluorescence 
intensities of individual samples in different time 
intervals were measured using a confocal 
microscope (Zeiss 510 Meta, Germany). 
 
Western blot analysis 
 
The expressions of apoptotic signaling and cell 
proliferation proteins were analyzed by Western 
blot. HeLa cells were treated with 12 µg/mL 
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sulforaphene and incubated for 3, 6, 12 and 24 
h. The whole protein was extracted using RIPA 
buffer (50mM Tris-HCl, pH 8.0, 1 % NP-40, 0.5 
% sodium deoxycholate, 150 mM NaCl, and 0.1 
% sodium dodecyl sulfate with protease and 
phosphatase inhibitor cocktail (Sigma, MO) and 
centrifuged at 15,000 rpm for 30 min at 4 ºC. The 
protein concentration was determined using BCA 
Reagent. Equivalent amounts of protein from 
each sample were loaded onto polyacrylamide 
gels and separated by electrophoresis. Then the 
proteins were transferred to PVDF membranes 
(Immuno-Blot PVDF, BioRad Laboratories, 
Hercules, USA). Both electrophoresis and 
blotting were performed using a PowerPac200 
electrophoresis system (BioRad Laboratories, 
Hercules, USA). The membranes were then 
blocked for 2 h at room temperature in Tris-
buffered saline containing 0.1 % Tween-20 and 5 
% skim milk. Then membrane was incubated 
overnight at 4 ºC with the primary antibody 
diluted with 3 % skim milk. The membranes were 
probed with horseradish peroxidase-conjugated 
to anti-mouse IgG or anti-rabbit IgG antibody for 
2 h. The protein bands were developed by ECL 
Western Blotting detection reagents (GE 
Healthcare, Buckinghamshire, UK) and the 
pictures were taken Kodak in vivo image 




All the data are expressed as mean ± SEM (n = 
3). Statistical analysis was performed and 
differences between two groups were analyzed 
using the two-tailed Student’s t-test. Differences 
between control and treated groups were 
analyzed using the Newman-Keuls one-way 
ANOVA test. P < 0.05, 0.01 or < 0.001 was 




Sulforaphene induces concentration- and 
time-dependent cytotoxicity in HeLa cells 
 
Sulforaphene was found to be cytotoxic and 
inhibited the growth of human cervical cancer 
HeLa cells. Figure 1(a) shows concentration and 
time dependent significant HeLa cell proliferation 
inhibition efficacy of sulforaphene. Based on 
MTT assay results, inhibitory concentration (IC50) 
values are 83.45 ± 2.52 µg/mL, 61.15 ± 2.24 
µg/mL, 22.64 ± 1.93 and 10.95 ± 1.73 after 3, 6, 
12 and 24 h respectively after sulforaphene 
treatment. With increase in incubation time after 




Sulforaphene induces apoptosis in HeLa cells 
 
The trigger of apoptosis by sulforaphene in HeLa 
cells was confirmed in confocal microscopic 
images after staining with Hoechst 33342 and PI. 
Figure 1(b) clearly shows the early and late 
apoptotic cells with bright fluorescence of 
condensed nucleus. In our experiment, as the 
treatment time increases, the percentage of 
normal cells decreases and percentage of 
apoptotic cells increases. At 12 h and 24 h 
incubation, maximum cells were found to be 
apoptotic and at 24 h few necrotic cells were also 
observed. Histogram indicates significant 
decrease in percentages of normal cells and 
significant increase in percentages of apoptotic 
cells after sulforaphene treatment at different 
intervals of time. 
 
Sulforaphene inhibits cell cycle progression 
and increases sub-G1 DNA content 
 
The flow cytometric analysis indicates that 
sulforaphene induced cytotoxicity of HeLa cells 
also involves inhibition of cell cycle progression 
and increases DNA content at sub-G1 level. 
Figure 2(a) shows that sulforaphene treatment 
causes significant increase in sub-G1 cell 
population in a time dependent manner. A 
significant reduction in cell population at the 
G0/G1 stage was observed with increase in 
treatment time. Sub-G1 cell population of control 
cells was found to be 5.1 ± 1.07 % whereas 22.5 
± 2.09 %, 36.5 ± 2.57 %, 45.1 ± 2.64 % and 59.0 
± 1.69 % were found after 3, 6, 12 and 24 h 
treatment, respectively. The histogram shows the 
percentages of cell count in different 
subpopulations. It also indicates that the number 
of apoptotic cells in sub-G1 region was 
significantly higher in all time intervals compared 
to the control group. Increase in the sub-G1 cells 
after sulforaphene treatment in all time intervals 
also indicates that HeLa cell proliferation was 
inhibited as and apoptosis was increased. 
 
Sulforaphene-induced apoptosis involves 
modulation of Bax and Bcl2 
 
Intracellular ROS generation is associated with, 
another important apoptotic process, Bax 
activation. So we analysed Bax expression in 
HeLa cells after sulforaphene treatment at 
different time intervals. As shown in Figure 3(a), 
sulforaphene treatment upregulates Bax 
expression and concomitantly down regulates 
Bcl2 expression in a time dependent manner. 
From the histogram of relative band intensities, 
sulforaphene treatment significantly increased 
Bax expression and decreased Bcl2 expression 
with time simultaneously. 






Figure 1: (a) The cytotoxicity of treated cells was studied by MTT assay. (b) Hoechst and PI double staining after 
sulforaphene treatment to study the apoptotic and necrotic cells a = p<0.05, b = p<0.01 and c = p<0.001 were 
considered as statistically significant 
 
Sulforaphene-induced apoptosis involves 
intracellular ROS generation   
 
Reactive oxygen species (ROS) induce cancer 
cell apoptosis by activation of capase cascade 
and therefore the generation of ROS in treated 
cells was tested to confirm whether ROS is 
involved in sulforaphene induced apoptosis. Flow 
cytometric analysis, in our experiment, figure 2(b) 
indicates that sulforaphene treatment stimulates 
intracellular ROS generation leading to increase 
in cell fluorescence at different time intervals. 
Approximately 45.43 ± 2.67 %, 63.04 ± 3.14 %, 
83.65 ± 1.51 % and 77.92 ± 4.10 % cells showed 
an increase in fluorescence after 3, 6, 12, 24 h, 
respectively. The percentage of fluorescent cells, 
which indicates intracellular ROS generation, 
were significantly increased with sulforaphene 
treatment compared to the control untreated cells 
in all time intervals. 
 
Sulforaphene-induced apoptosis involves 
mitochondrial depolarization and cytochrome 
c, AIF higher expression 
 
Intracellular ROS generation and Bax/ Bcl2 
modulation strongly suggest mitochondrial 
damage and mitochondrial membrane 
depolarization by sulforaphene treatment. 
Therefore we investigated changes in 
mitochondrial membrane potential (Δψm) by 
confocal microscopy and flow cytometry. 
Confocal images in figure 3(b) of our experiment, 
indicates reduction in relative green fluorescence 
in treated cells compared to the control cells. 
Δψm noticeably reduced after 3 and 6 h 
sulforaphene treatment, however, after 12 and 
24 h, Δψm was also found to decrease than 
respective control. The fluorescence intensity 
correlate with the time dependent differential 
changes in Δψm. 
 





Figure 2: (a) Flow cytometric analysis of cell cycle after sulforaphene treatment at different time intervals. (b) 
Intracellular ROS increases with time after sulforaphene treatment. a = p<0.05, b = p<0.01 and c = p<0.001 were 
considered as statistically significant 
 
These time dependent decrease in Δψm were 
significant compared to their respective control. 
Sulforaphene treatment induced time dependent 
mitochondrial membrane depolarization was also 
confirmed by flow cytometry. Histograms in figure 
3(c) shows 29.6, 36.4, 34.9 and 57.6 % cells 
reduced fluorescence intensity after sulforaphene 
treatment for 3, 6, 12 and 24 h, respectively. This 
time dependent mitochondrial depolarization 
promotes the release of cytochrome c and AIF 
which in turn induce mitochondria mediated 
apoptosis. In this experiment, sulforaphene 
treatment was found to increase the expressions 
of cytosolic cytochrome c and AIF. In figure 3(d) 
higher expression of cytochrome c was observed 
at 6 and 12 h whereas expression of AIF was 
higher at 3 and 6 h. Therefore the time-
dependent decrease in Δψm and cytochrome c 
and AIF expression confirmed that sulforaphene 
treatment activates mitochondrial apoptotic 
pathway in HeLa cell. 
 
Sulforaphene-induced apoptosis involves 
modulation of caspases and cleavage of 
PARP 
 
To evaluate the pathway of apoptosis after 
sulforaphene treatment the expressions of 
caspase 9, caspase 8, pro-caspase 3 and PARP 
were analyzed by western blot. From figure 4(a) 
caspase 9 expression was elevated with time 
and highest expression was found at 6 h after 
treatment. 
 






Figure 3: (a) Modulation of Bax and Bcl2 expression after sulforaphene treatment at different time intervals. (b) 
mitochondrial membrane depolarization with rhodamine 123 (ap < 0.05, bp < 0.01, cp < 0.001. (c) Mitochondrial 
membrane potential of the cells. Cells in the right section of the histogram (V1-R) indicates normal cells with high 
fluorescence while the left side (V1-L) indicates cells with lower fluorescence, indicating depolarization of 
mitochondrial membrane potential. (d) Cytochrome c and AIF expression after sulforaphene treatment 
 
In case of caspase 8, time dependent higher 
expression was observed and at 24 h cleaved 
form was observed. On the other hand time 
dependent modulation of caspase 3 was also 
observed after sulforaphene treatment. 
Expression of pro-caspase 3 in western blot 
analysis was observed to be decreased with time 
which indicates higher expression of active 
caspase 3. Hence we checked active caspase 3 
by immunofluorescence staining. Results in 
figure 4 (b) clearly indicate time dependent 
increase of active caspase 3 after sulforaphene 
treatment. Highest active caspase 3 fluorescence 
intensity was observed for 12 h. After 24 h of 
sulforaphene treatment, maximum cells were 
found to be dead and the fluorescence intensity 
observed was less compared to the other 
treatment groups. Another downstream protein 
PARP was also found to be cleaved with time in 
sulforaphene treatment. As time increases, 
cleaved PARP expression was found to be 
increased.   
 
Sulforaphene inhibits HeLa cell proliferation 
by activating PTEN and inactivating 
PI3Kinase  
 
PI3Kinase has very important function in cell 
survival, cell differentiation and cell proliferation.. 
To determine whether sulforaphene can inhibit 
this cellular process via activation of PTEN and 
deactivation of PI3Kinase, we performed western 
blot analysis. Our experimental data in figure 4 
(c) clearly demonstrated that PTEN expression 
increased with increasing time, whereas 
PI3kinase expression was found to be 
decreased. This time dependent increase of 
PTEN expression and decrease of PI3Kinase 
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was higher at 12 and 24 h after sulforaphene 
treatment. Relative band intensity histogram 
clearly indicates the time dependent significant 




Individual side effects of different cervical cancer 
modalities are the main disadvantage and have 
thrown this cancer as a challenge to the human 
being. Therefore introduction of some novel 
therapeutics without any adverse side effects is 
now highly recommended. Cruciferous 
vegetables like broccoli, cabbage, cauliflower, 
radish, mustard, etc. have already been reported 
for their anti-proliferative, anti-inflammatory, 
antioxidant and anticancer properties due to 
presence of various isothiocyanates [21].  
 
The present study demonstrated that radish 
derived isothiocyanate sulforaphene treatment 
can reduce the viability of HeLa cells in both 
dose and time dependent manner. Sulforaphene 
induced time dependent apoptotic response was 
confirmed by the morphological changes with 
progressive detachment of cells containing 
condensed and fragmented chromatin along with 
reduction in cell viability. On the other hand, time 
dependent increase in sub-G1 cell population 
and concomitant decrease in G0/ G1 phase 
population after sulforaphene treatment suggest 
the efficacy of sulforaphene in arresting cell 
division and cell proliferation inhibition on human 
cervical cancer cells. Thus there was clear 
evidence that sulforaphene could bring about 
both cellular apoptosis and cell cycle progression 
inhibition in HeLa cells. 
      
     
 
Figure 4: (a) Modulation of expressions of caspase 9, caspase 8, pro-caspase 3 and cleavage of PARP in active 
form. (b) Confocal microscopic analysis of active caspase 3 activity after sulforaphene treatment. (c) Alteration 
expressions of PTEN and PI3Kinase. a = p<0.05, b = p<0.01 and c = p<0.001 were considered as statistically 
significant 
 
Reactive oxygen species (ROS) generation is 
responsible for the intracellular oxidative stress 
related mitochondrial membrane depolarization 
resulting in the activation of mitochondrial 
pathway of apoptosis [22]. In this present study, 
sulforaphene treatment increased intracellular  





Figure 5: Schematic diagram represents intracellular ROS generation and modulation of pathway related 
signaling proteins after sulforaphene treatment in HeLa cells 
 
ROS generation and subsequently enhanced 
pro-apoptotic Bax expression. Enhanced Bax, 
down regulates the anti-apoptotic protein Bcl2, 
which is the indication of mitochondrial 
membrane permeability change and activation of 
mitochondrial intrinsic pathway of programmed 
cell death [23]. Our data revealed that 
sulforaphene treatment decreased mitochondrial 
membrane potential in a time dependent manner 
and consequently increased the expressions of 
cytochrome c and AIF. This cytochrome c 
activates another mitochondrial pathway protein, 
caspase 9. On the other hand, sulforaphene 
treatment was also found to modulate the 
extrinsic pathway related protein, caspase 8. 
Activated caspase 8 and caspase 9 further 
activate one of the most important apoptosis 
regulating protein, caspase 3. Downstream 
protein PARP also found to be cleaved to its 
active form after sulforaphene treatment. Taken 
together, intracellular ROS plays a causative role 
in sulforaphene treated HeLa cells by the 
activation of mitochondrial pathway of 
programmed cell death. In the present study anti-
apoptotic Bcl2 down-regulation and pro-apoptotic 
Bax up-regulation and further depletion of 
mitochondrial membrane potential indicates that 
mitochondria play a central role in sulforaphene 
induced apoptosis in HeLa cells. Higher 
expressions of cytochrome c and AIF also 
coincided with the mitochondrial membrane 
potential depletion and subsequent activation of 
caspase 9 and caspase 3. Moreover, caspase 8 
was also involved in the sulforaphene mediated 
apoptosis. Therefore, higher expression of 
different caspases in our study could suggest 
that the apoptotic action of sulforaphene might 
be mediated through the activation of caspases. 
 
The phosphatidylinositol 3-kinase (PI3Kinase) 
and phosphatase and tensin homolog (PTEN) 
are the two key signaling components which very 
frequently mutated in human cancers. Activated 
of PI3Kinase pathway regulates several cellular 
processes such as survival, proliferation, 
metabolism and growth resulting in 
tumorigenesis, migration and invasion [24]. On 
the other hand, PI3Kinase activity in the cancer 
cells is tightly regulated by the opposing activity 
of PTEN. Moreover, PTEN appears as a 
suppressor of cancer cell growth by cell cycle 
arrest and inducing apoptosis [25]. In the present 
study, the expression of PI3Kinase decreased 
and concomitantly the expression PTEN 
increases in a time dependent manner after 
sulforaphene treatment in HeLa cells. Based on 
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this result, it can be suggested that the dietary 
isothiocyanate, sulforaphene can inhibit cervical 
cancer cell proliferation and further functions by 
PI3Kinsase inhibition and PTEN activation. 
Figure 5 schematically demonstrate sulforaphene 
activity in the modulation of different pathway 
related proteins in HeLa cells.  
 
Therefore, our present study is directed towards 
understanding the preliminary mechanisms in 
sulforaphene activity in HeLa cells. First, 
sulforaphene induced ROS appeared to play a 
crucial role in Bax/Bcl2 modulation as well as 
mitochondrial damage and cytochrome c and AIF 
higher expression. Second, sulforaphene 
treatment activates caspase 9-, 8-, 3- and 
cleaves PARP which leads HeLa cells to 
apoptosis. Third, sulforaphene down-regulates 
PI3Kinase and up-regulates PTEN resulting in 
inhibition of HeLa cell proliferation. However, 
more studies are required to overcome other 
detailed concerns including animal experiments 
but in the present study sulforaphene 
preliminarily qualifies as a better candidate and 
potent anticancer agent for therapeutic 
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